Glycyrrhizin prevents SARS-CoV-2 S1 and Orf3a induced high mobility group box 1 (HMGB1) release and inhibits viral replication
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- β-defensin-3 negatively regulates TLR4–HMGB1 axis mediated HLA-G expression in IL-1β treated glioma cellsCellular Signalling, 2013
- Tumor-Cell Co-Culture Induced Alternative Activation of Macrophages Is Modulated by Interferons In VitroJournal of Interferon & Cytokine Research, 2012
- Increased levels of cytokines and high-mobility group box 1 are associated with the development of severe pneumonia, but not acute encephalopathy, in 2009 H1N1 influenza-infected childrenCytokine, 2011
- Glycyrrhizin Exerts Antioxidative Effects in H5N1 Influenza A Virus-Infected Cells and Inhibits Virus Replication and Pro-Inflammatory Gene ExpressionPLOS ONE, 2011
- HMGB1 Is a Therapeutic Target for Sterile Inflammation and InfectionAnnual Review of Immunology, 2011
- Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathwayBlood, 2010
- Alternative Activation of Macrophages: An Immunologic Functional PerspectiveAnnual Review of Immunology, 2009
- Glycyrrhizin Binds to High-Mobility Group Box 1 Protein and Inhibits Its Cytokine ActivitiesChemistry & Biology, 2007
- Caspase-1-dependent processing of pro-interleukin-1β is cytosolic and precedes cell deathJournal of Cell Science, 2007
- The cytokine activity of HMGB1Journal of Leukocyte Biology, 2005